2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
74
Colorectal Neoplasms
41
Central Nervous System Neoplasms
37
Colonic Neoplasms
36
Rectal Neoplasms
34
Glioblastoma
23
Carcinoma, Non-Small-Cell Lung
21
Gliosarcoma
20
Stomach Neoplasms
18
Lung Neoplasms
18
Pancreatic Neoplasms
16
Head and Neck Neoplasms
16
Sarcoma
14
Ovarian Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
13
Prostatic Neoplasms
12
Neoplasm Metastasis
11
Melanoma
11
Esophageal Neoplasms
11
Carcinoma, Ovarian Epithelial
11
Carcinoma, Intraductal, Noninfiltrating
11
Astrocytoma
11
Fallopian Tube Neoplasms
10
Brain Neoplasms
10
Uterine Cervical Neoplasms
9
Kidney Neoplasms
9
Breast Carcinoma In Situ
9
Liver Neoplasms
8
Breast Neoplasms, Male
8
Adenocarcinoma Of Esophagus
8
Interventions
Gemcitabine
95
Cisplatin
72
Capecitabine
39
Oxaliplatin
38
durvalumab
29
Fluorouracil
27
pembrolizumab
26
Leucovorin
23
S 1 (combination)
19
Nivolumab
14
Irinotecan
14
lenvatinib
13
Bevacizumab
13
tremelimumab
10
130-nm albumin-bound paclitaxel
9
apatinib
8
Trastuzumab
7
Injections
7
Immune Checkpoint Inhibitors
7
Docetaxel
7
Albumin-Bound Paclitaxel
7
Paclitaxel
6
Drug Therapy
6
titanium silicide
5
surufatinib
5
irinotecan sucrosofate
5
gemcitabine-oxaliplatin regimen
5
envafolimab
5
camrelizumab
5
atezolizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Chemotherapy, Adjuvant
×
Clear all
NCT07184047
2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
72 enrolled
NCT03673072
2024-11-12
GAIN
Krankenhaus Nordwest
Phase 3
Completed
68 enrolled